Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Miye N. COHEN |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Effect of methylphenidate hydrochloride on stature of hyperactive children / John E. KALACHNIK in Developmental Medicine & Child Neurology, 24-5 (October 1982)
[article]
Titre : Effect of methylphenidate hydrochloride on stature of hyperactive children Type de document : Texte imprimé et/ou numérique Auteurs : John E. KALACHNIK, Auteur ; Robert L. SPRAGUE, Auteur ; Esther K. SLEATOR, Auteur ; Miye N. COHEN, Auteur ; Rina K. ULLMANN, Auteur Année de publication : 1982 Article en page(s) : p.586-595 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Twenty-six hyperactive children receiving methylphenidate hydrochloride, eight hyperactive non-medicated children and 25 normal children participated in a study of the effect of such medication on stature of hyperactive children. All the children were below 13 years of age and all but two were male. Predicted adult stature before methylphenidate treatment and predicted adult stature after one year, two years and three years of treatment were calculated by means of the Roche-Weiner-Thissen Adult Stature Prediction Formula. Total milligrams per day dosage, milligrams per kilogram per day dosage and duration of treatment per year were analysed in the medicated hyperactive children and their growth was compared with the other two groups. No significant differences were found for any of the above variables. This study indicates that stature suppression does not occur in male children below 13 years of age when methylphenidate is used up to 0.8mg/kg/day for one or two years and up to 0.6mg/kg/day for three years. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=531
in Developmental Medicine & Child Neurology > 24-5 (October 1982) . - p.586-595[article] Effect of methylphenidate hydrochloride on stature of hyperactive children [Texte imprimé et/ou numérique] / John E. KALACHNIK, Auteur ; Robert L. SPRAGUE, Auteur ; Esther K. SLEATOR, Auteur ; Miye N. COHEN, Auteur ; Rina K. ULLMANN, Auteur . - 1982 . - p.586-595.
Langues : Anglais (eng)
in Developmental Medicine & Child Neurology > 24-5 (October 1982) . - p.586-595
Index. décimale : PER Périodiques Résumé : Twenty-six hyperactive children receiving methylphenidate hydrochloride, eight hyperactive non-medicated children and 25 normal children participated in a study of the effect of such medication on stature of hyperactive children. All the children were below 13 years of age and all but two were male. Predicted adult stature before methylphenidate treatment and predicted adult stature after one year, two years and three years of treatment were calculated by means of the Roche-Weiner-Thissen Adult Stature Prediction Formula. Total milligrams per day dosage, milligrams per kilogram per day dosage and duration of treatment per year were analysed in the medicated hyperactive children and their growth was compared with the other two groups. No significant differences were found for any of the above variables. This study indicates that stature suppression does not occur in male children below 13 years of age when methylphenidate is used up to 0.8mg/kg/day for one or two years and up to 0.6mg/kg/day for three years. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=531